Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP422619.RAhfNCi67fdQM4tYJ09htFs-LYrhl5zSU6eWisQxgdIKg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP422619.RAhfNCi67fdQM4tYJ09htFs-LYrhl5zSU6eWisQxgdIKg130_assertion type Assertion NP422619.RAhfNCi67fdQM4tYJ09htFs-LYrhl5zSU6eWisQxgdIKg130_head.
- NP422619.RAhfNCi67fdQM4tYJ09htFs-LYrhl5zSU6eWisQxgdIKg130_assertion description "[LZTS1 has been shown to have tumour suppressor activities against prostate and breast cancer and is located within a region of frequent loss of heterozygosity (LOH) at 8p22 in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP422619.RAhfNCi67fdQM4tYJ09htFs-LYrhl5zSU6eWisQxgdIKg130_provenance.
- NP422619.RAhfNCi67fdQM4tYJ09htFs-LYrhl5zSU6eWisQxgdIKg130_assertion evidence source_evidence_literature NP422619.RAhfNCi67fdQM4tYJ09htFs-LYrhl5zSU6eWisQxgdIKg130_provenance.
- NP422619.RAhfNCi67fdQM4tYJ09htFs-LYrhl5zSU6eWisQxgdIKg130_assertion SIO_000772 15876481 NP422619.RAhfNCi67fdQM4tYJ09htFs-LYrhl5zSU6eWisQxgdIKg130_provenance.
- NP422619.RAhfNCi67fdQM4tYJ09htFs-LYrhl5zSU6eWisQxgdIKg130_assertion wasDerivedFrom befree-20140225 NP422619.RAhfNCi67fdQM4tYJ09htFs-LYrhl5zSU6eWisQxgdIKg130_provenance.
- NP422619.RAhfNCi67fdQM4tYJ09htFs-LYrhl5zSU6eWisQxgdIKg130_assertion wasGeneratedBy ECO_0000203 NP422619.RAhfNCi67fdQM4tYJ09htFs-LYrhl5zSU6eWisQxgdIKg130_provenance.